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ABSTRACT
The article examined the procedural criterion based on “accountability for reasonableness” as 
an auxiliary method to the jurisdictional control in health care litigation, especially given the 
creation of the National Commission for Health Technology Incorporation in the Brazilian 
National Health System. It was studied how the influx of pragmatism in the courts works 
suggests a diverse judicial model for the implementation of the right to health in an attempt 
de-judicialize the debate and the decrease the risks to equity in the distribution of resources. 
Empirical data collected through literature review were used to analyze the concrete perfor-
mance of the Commission. It was concluded that the greater jurisdictional control over the 
administrator’s decision-making procedure regarding the inclusion of medicines in public lists 
may be a pragmatic judicial stance to produce better results, by requiring the public adminis-
tration to account for their actions and to demonstrate the reasons for the allocated decisions 
on pharmaceutical assistance, as well as stimulating social participation in the procedure.
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RESUMO
O artigo examinou o critério procedimental baseado na accountability para a razoabilidade 
(accountability for reasonableness) como um método auxiliar ao controle jurisdicional nos 
litígios de saúde, sobretudo diante da criação da Comissão Nacional de Incorporação de 
Tecnologias no Sistema Único de Saúde. Estudou-se como o influxo do pragmatismo na 
atuação das cortes sugere um modelo judicial diverso para a concretização do direito à saúde, 
na tentativa de desjudicializar o debate e diminuir os riscos à equidade na distribuição dos 
recursos. Utilizaram-se dados empíricos colhidos por meio de revisão bibliográfica para 
análise da atuação concreta da Comissão. Concluiu-se que o maior controle jurisdicional do 
procedimento de tomada de decisão do administrador acerca da inclusão de medicamento 
nas listas públicas pode ser uma postura judicial pragmática tendente a produzir melhores 
resultados, ao exigir que a administração pública preste contas de sua atuação e demonstre 
as razões das decisões alocativas na assistência farmacêutica, bem como ao estimular a parti-
cipação social no procedimento.
Palavras-Chave 
Accountability for Reasonableness; Direito Constitucional; Litígios de Saúde.
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Introduction
Life is priceless. The guarantee of the constitutional right to health by the 
State must take into account an ideal distribution of public resources that allows 
maximizing the health protection of the entire population. For this task, it is up to 
the State to define priorities and elaborate a difficult calculation in relation to the 
allocation of resources.
Of the total deaths occurred in Brazil annually, about 70% are related to 
chronic non-communicable diseases: cardiovascular diseases, respiratory diseases, 
cancer and diabetes. A considerable portion of these deaths is premature, that is, it 
affects people aged 30 to 69 years and could have been avoided.
These diseases have a great socioeconomic impact, divided between the 
health system, society and families, and create a vicious circle with poverty. Its pre-
ponderance in causes of mortality constitutes the health problem of greatest mag-
nitude in the country, and its confrontation has become a priority at the national 
level. From 2000 to 2014, the biggest decreases in premature mortality rates occurred 
in the Southeast and South (-5.6%) and the smallest, in the Northeast (-1.9%). For 
diabetes, the premature mortality rate increased in the North1.
In 2014, of the total spent by the Ministry of Health to comply with court 
orders, 55% (R$ 381 million) referred to two medications: Soliris® and Naglazyme®, 
both demanded for the treatment of patients with rare diseases and not included in 
the drug lists of the Brazilian National Health System (SUS) nor in the Clinical Pro-
tocols and Therapeutic Guidelines (PCDT). These are the drugs that generated the 
highest cost for the Ministry of Health that year, intended to treat only 382 patients; 
the average annual cost per patient was R$ 941,541.19 in the case of Soliris®, and R$ 
1,081,594.78 in the case of Naglazyme® (item 4.1, Case 009.253/2015-7, Judgment 
1787/2017, rapporteur of Bruno Dantas, session of August 16, 2017, plenary session 
of the Federal Court of Accounts)2.
The data cited are examples of the contrasting situations that health author-
ities have to deal with when formulating pharmaceutical assistance policy. How to 
provide the treatment for cardiovascular diseases and diabetes, which prematurely 
kill thousands of individuals, and, at the same time, for rare diseases that require 
expensive drugs, which is inaccessible by the patients’ own means? Inevitably, the 
finitude of resources requires that tragic choices be made.
1 MINISTÉRIO DA SAÚDE. Saúde Brasil 2015/2016: uma análise da situação de saúde e da epidemia pelo 
vírus Zika e por outras doenças transmitidas pelo Aedes aegypti. Brasília-DF: Ministério da Saúde, 2017. 
p. 119-125.
2 AUMENTAM os gastos públicos com judicialização da saúde. Tribunal de Contas da União, 23 out. 2017. 
Available at: http://portal.tcu.gov.br/imprensa/noticias/aumentam-os-gastos-publicos-com-judicializacao-
da-saude.htm. Acesso em: 14 Oct. 2020.
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It is not considered, in this regard, weighting between the right to health 
and the public budget, as they are not in the same hierarchy. It is about the need to 
prioritize, requiring that the real costs and possibilities of implementation be con-
sidered, as well as the effectiveness and security of the treatment, for an equitable 
allocation of resources.
In Brazil, however, jurisprudence in general has given little importance to 
the decision-making procedure of administrative authorities. In this scenario, it 
would be appropriate to consider another judicial model for the implementation of 
the right to health, in an attempt to gradually reduce judicialization in the country 
and to reduce the risks to equity in the distribution of scarce resources of a health 
system that belongs to all, litigants or not? Or, instead, the solution would be to 
maintain the current judicial interpretation and restructure the Judiciary in order 
to prepare it to receive an increasing number of demands? In our view, the latter 
does not seem to be the most appropriate solution to this challenge. We, therefore, 
dedicate ourselves to answering the first question.
We emphasize how the influx of pragmatism in the performance of 
judges and courts in the effectiveness of the right to health imposes a different 
attitude to that prevailing in national jurisprudence, in an attempt to obtain less 
unequal and more universal practical results and to de-judicialize the debate. 
To this end, a good tool for the judge is the adoption of the procedural criteria 
based on accountability for reasonableness, approached as an auxiliary method 
in jurisdictional control that favors interventions over the administrator’s deci-
sion-making procedure on the inclusion of medicines in public lists, especially 
in view of the creation of the National Commission for Technology Incorpora-
tion at SUS (Conitec).
I. The influx of legal pragmatism in health care litigation
The result of the most recent audit carried out by the Federal Court of 
Accounts (TCU), completed in 2017, revealed that annual expenditures only 
by the federal government with judicial process related to health reached R$ 1 
billion in 2015, which is equivalent to an increase of more than 1,300% since 2008, 
when it was R$ 70 million. Among the demands in 2015, 80% corresponded to 
the supply of medicines (item 7.2, Case 009.253/2015-7, Judgment 1787/2017, 
rapporteur of Bruno Dantas, session of August 16, 2017, plenary session of the 
Federal Court of Accounts)3.
Empirical data from national and regional studies demonstrate that 
most of the demands have not aimed at providing basic health to the most needy 
3 AUMENTAM os gastos públicos com judicialização da saúde, cit.
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population4: the aim is to obtain newer and more expensive drugs compared to 
those dispensed by SUS, make use drugs outside the prediction of the clinical pro-
tocol and, in both cases, it is not uncommon to disregard the safety and efficacy 
of drugs and the cost-effectiveness of their dispensing. Furthermore, the studies 
indicate a concentration of lawsuits in the most developed states in the country.
However, the analysis of the jurisprudence of the Federal Supreme Court 
(STF) on health in the period from 2000 to 2017 shows that the judicial debate is 
still centered, for the most part, on the collision between the right to life and health 
and the financial and secondary interest of the State, giving less weight - or even 
completely disregarding - to the context, the financial and organizational impacts 
on the health system and the litigants who claim medicines, as well as the scarcity 
of resources and the reasons of the health authorities in the administrative proce-
dures for drugs evaluation5.
The demands for pharmaceutical assistance not foreseen in the SUS lists or 
in the clinical protocols filed by private individuals in the face of federative entities 
involve scarcity of public resources, controversies about the setting of health priori-
ties and issues of distributive justice. Therefore, they represent difficult cases, which 
generate impacts on the entire health system and which require a differentiated 
decision-making strategy, more committed to reality and to the practical results 
of decisions. From this scenario, this research valued the pragmatism, due to the 
importance it gives to the context and the consequences of the interpretation and 
application of the law. It is not the central object of our study to discuss in depth 
philosophical or theoretical issues related to the subject. We only intend to apply 
a pragmatic approach to health care litigation and, for this, there is no need for an 
unconditional adherence to the proposals of pragmatism.
4 For a detailed analysis of the demands, see: TAUK, Caroline Somesom. Expectativa e realidade: uma análise 
pragmática dos litígios de saúde. Revista Brasileira de Direito Público. Belo Horizonte, v.18, n.68, jan./mar. 
2020. Available at: https://dspace.almg.gov.br/handle/11037/37383;CHIEFFI, Ana Luiza; BARRADAS, Rita 
De Cassia Barata; GOLBAUM, Moisés. Legal access to medications: a threat to Brazil’s public health system? 
Health Serv. Res., v.17, n. 499, p. 1-12, 2017. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC5517947/. Acesso em: 09 Oct. 2018. https://doi.org/10.1186/s12913-017-2430-x; VIEIRA, Fabiola 
Sulpino; ZUCCHI, Paola. Distorções causadas pelas ações judiciais a política de medicamentos no Brasil. Rev. 
de Saúde Pública, vol. 41, n.2, p. 215-222, 2007. Available at: http://www.scielo.br/pdf/rsp/v41n2/5587.
pdf. Acesso em: 09 Oct. 2018. http://dx.doi.org/10.1590/S0034-89102007000200007; FERRAZ, Octavio 
Luiz Motta. Harming the poor through social rights litigation: lessons from Brazil. Texas Law Review, v. 89, 
p. 1642-1668, 2011. Available at: https://texaslawreview.org/wp-content/uploads/2015/08/Ferraz-89-
TLR-1643.pdf e MACHADO, Marina Amaral de Avila et al. Judicialização do acesso a medicamentos no 
Estado de Minas Gerais, Brasil. Rev. Saúde Pública, v. 45, n. 3, p. 590-598, 2011. Available at: https://
www.scielo.br/pdf/rsp/v45n3/2403.pdf.
5	This	 is	what	 is	verified	 in	 the	following	 judgments,	 to	name	a	few:	AgR	no	RE	232335,	de	25/08/2000,	
Rel. Min. Celso de Mello; ADPF 45, de 04/05/2004, Rel. Min. Celso de Mello; STAs 175 e 178, de 2009, 
Rel. Min. Gilmar Mendes; ARE 685230 AgR, de 05/03/2013, Rel. Min. Celso de Mello, ARE 744170 AgR, 
de 26/11/2013, Rel. Min. Marco Aurélio, ARE 812424 AgR, de 05/08/2014, Rel. Min, Celso de Mello, AI 
824946 ED, de 25/06/2013, Rel. Min. Dias Toffoli e ARE 926469 AgR, de 07/06/2016, Rel. Min. Roberto 
Barroso. Disponível em: www.stf.jus.br. Acesso em: 09 out. 2018.
119
Accountability for reasonableness in health care: A proposal for a procedural enforcement
R. Dir. sanit., São Paulo v.20 n.3, p. 114-138, nov. 2019/fev. 2020
The philosophical current of pragmatism was well synthesized by Thamy 
Pogrebinschi, who, from the works of the first classical pragmatists (Charles S. 
Peirce and William James, members of the so-called Metaphysical Club, and also 
John Dewey), identified a common nucleus in the movement conceived for them. 
Thus, the matrix of pragmatism was formulated, composed of three main ideas: 
antifundationalism, consequentialism and contextualism.
Antifundationalism is characterized by rejection of metaphysical propo-
sitions. It presupposes that there are no absolute and finished truths, maintaining 
that the traditional concepts of certainty, reality and truth, elaborated along the lines 
of traditional metaphysics, must be submitted to a new method. In the pragmatist 
method, the meaning of each concept will depend on its practical consequences6.
The second element of the philosophical matrix of pragmatism, the conse-
quentialism, also called instrumentalism, refers to the concern for the future, that 
is, the prospective view of pragmatism. It is by anticipating the future consequences 
that one can know which of them is better and more useful. For pragmatism, all 
propositions are hypothetical and must be tested by deducing their consequences7.
Finally, contextualism determines that philosophical investigations must 
be made from their specific contexts, highlighting the relationship between philo-
sophical ideas, social life and the culture of the society from which the ideas origi-
nated. Discuss about culture of a society means to discuss the political, religious and 
scientific beliefs that make up the experience. The main constituent element of the 
experience is the practice, which refers directly to the formulation of the pragmatist 
concept of action. Therefore, experience and practice are valued8.
The three characteristics of the pragmatic matrix are interrelated in the 
conclusion of José Vicente Santos de Mendonça: “[...] if there are no foundations 
that justify or validate concepts and theories, one must appreciate from their conse-
quences, which only acquire meaning within the context in which they are inserted”9.
Dealing with pragmatism in the field of law, Richard Posner points out that 
there is, in fact, a pragmatic mood that branched into a philosophy of pragmatism 
and into an everyday practice of pragmatism10. Looking at its consequences is the 
first aspect to understand what Posner’s everyday pragmatism is. To this, the author 
adds (i) the disbelief in concepts regarded as certain and immutable and (ii) the use 
of several theories for the proper understanding of law, as well as (iii) the need for 
6 POGREBINSCHI, Thamy. Pragmatismo: teoria social e política. Rio de Janeiro: Relume Demará, 2005, p.31.
7 Id. Ibid., p. 39; 47.
8 Id. Ibid., p. 49.
9 MENDONÇA, José Vicente Santos de. Direito constitucional econômico: a intervenção do Estado na 
economia à luz da razão pública e do pragmatismo. Belo Horizonte: Forum, 2014. p. 38.
10 POSNER, Richard. A. Law, pragmatism and democracy. Cambridge: Harvard University Press, 2003. p. 26.
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its conformity with human and social needs11. In fact, these three elements refer, 
respectively, to the three elements of the pragmatic matrix: consequentialism, anti-
fundationalism and contextualism.
In short, a pragmatic approach seeks to understand the right to health in the 
concrete context in which it is inserted, with the vision aimed at seeking solutions 
to practical questions. Against this background, the stage opens for the debate of 
another judicial model for the implementation of the right to health, in an attempt to 
de-judicialize conflicts and reduce the risks to equity in the distribution of resources.
II. The judicial implementation of the right to health: the individual and 
procedural models
The Federal Constitution of 1988 (CF/88) consolidated a theory of funda-
mental rights centered on the dignity of the human person. This theory must be 
understood with attention to the reality in which it will be applied. It is the conclu-
sion of Ana Paula de Barcellos:
There is no right without reality. It is reality what the right intends 
to transform and it is from it that right extracts the new needs 
and demands to be regulated; it is the reality that confronts the 
interpreter with the most intricate problems and drives him to 
work; it is from reality that the right cannot go beyond a certain 
limit, under pain of losing contact and walking alone and without 
meaning, unable to bring it closer to the law. The right, therefore, 
is a truism, is an instrument, it is a means, not an end in itself12.
Regarding fundamental rights, there is much debate about the syndicability 
of social rights, including the right to health. In fact, judicial intervention in the 
right to health - the so-called judicialization of health - faces several criticisms13. 
However, the judicial action in the implementation of the right to health in Brazil 
is an undeniable reality, due to the normativity and effectiveness of constitutional 
provisions. For this reason and for the purposes of our study, we start from the 
11 POSNER, Richard. A what has pragmatism to offer law. Southern California Law Review, v. 63, n. 1660, 
1989-1990. Available at: https://pdfs.semanticscholar.org/4880/3eecdcb20b0bbd1510890fdc6b936
9ad48b2.pdf.
12 BARCELLOS, Ana Paula de. A eficácia jurídica dos princípios constitucionais: o princípio da dignidade da 
pessoa humana. 2. ed. Rio de Janeiro: Renovar, 2008. p. 5.
13 For an objective survey of the various criticisms, see: BARROSO, Luís Roberto. Da falta de efetividade à 
judicialização excessiva: direito à saúde, fornecimento gratuito de medicamentos e parâmetros para a 
atuação judicial. Jurisp. Mineira, Belo Horizonte, ano 60, n. 188, p. 44-46, jan./mar. 2009; e BARCELLOS, 
Ana Paula de. Constitucionalização das políticas públicas em matéria de direitos fundamentais: o 
controle político-social e o controle jurídico no espaço democrático. In: SARLET, Ingo Wolfgang; TIMM, 
Luciano Benetti (Orgs.). Direitos fundamentais, orçamento e reserva do possível. Porto Alegre: Livraria 
do Advogado, 2008.
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premise that the syndicability of social rights is possible and, more than that, fun-
damental to ensure that public policies comply with the Constitution and the laws.
However, such premise does not put an end to the discussions. How should 
the Judiciary intervene? It is at this point that the models of jurisdictional control 
vary the most among countries. In Brazil, the majority jurisprudence has widely 
accepted the granting of medicines by individual, with the use of strong remedies, 
determining to the public authority the fulfilment of the exact required provision, 
by supplying the medicine in a short time, under penalty of a fine or other enforce-
ment measure14.
Courts in some other countries adopt the procedural model, following an 
approach based on the reasonableness of the administrative decision-making pro-
cedure. This is the case of the Constitutional Court of South Africa, which requires 
the government to justify its actions in order to verify whether it has proceeded 
reasonably towards the implementation of social and economic rights. The doctrine 
and the Constitutional Court south African raise three questions regarding the inter-
pretation of social rights: the separation of powers, the vagueness of the rules that 
deal with those rights and the costs for their implementation. The emblematic case 
of South African jurisprudence is called “Soobramoney versus Minister of Health, 
Kwazulu-Natal” [1998 (1) SA 765 (CC)] “15.
In the scenario of greater or lesser judicial intervention in the consolidation 
of rights, the dilemma proposed by Frank Michelman and studied by Octavio Fer-
raz16arises: given the vagueness of the content of social rights and the existence of 
reasonable disagreement about it, the Judiciary must exercise caution when replace 
the interpretation made by elected officials with their own interpretation of the 
content of the rights, reason why the use of strong judicial remedies to impose their 
interpretation attracts the charge of “usurpation”; however, given the general view 
that courts are guardians of fundamental rights, abstaining from the use of strong 
remedies when judging social rights may imply “abdication”.
A strongly respectful model can pave the way for a total disregard for social 
rights by health authorities, especially in countries with high levels of corruption 
and non-compliance with the constitutional duties of the State, such as Brazil and 
South Africa, as highlighted by Ferraz. In contrast, allowing the courts to completely 
14 FERRAZ, Octavio Luiz Motta. Between usurpation and abdication? The right to health in the Courts of 
Brazil and South Africa. University of Warwick School of Law, 2009. p. 12. Available at: http://ssrn.com/
abstract=1458299. Acesso em: 09 Oct. 2018. http://dx.doi.org/10.2139/ssrn.1458299.
15 EBADOLAHI, Mitra. Using Structural Interdicts and the South African Human Rights Commission to Achieve 
Judicial Enforcement of Economic and Social Rights in South Africa. New York University Law Review, v. 83, 
n. 5, p. 1580-1582, 2008. Available at: https://www.nyulawreview.org/wp-content/uploads/2018/08/
NYULawReview-83-5-Ebadolahi.pdf.
16  FERRAZ, Octavio Luiz Motta. Between usurpation and abdication? The right to health in the Courts of Brazil 
and South Africa, cit., p. 6.
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disregard the priority and allocation decisions made by elected officials and experts 
may also not be the best way out.
Specifically dealing with the setting of health priorities, the North American 
professors Norman Daniels and James Sabin17 propose a theory, called accountability 
for reasonableness, which seeks to verify how health priorities are established by 
public authorities in order to ensure that health care in based on fair procedures 
leading to fundamental administrative choice, publicly accepted and that respect 
equity, increasing the legitimacy of the results. It takes care of procedural criteria 
for setting priorities by the public administration that can also be used by judicial 
bodies, in the form of a procedural control, but with its own characteristics.
And why, based on pragmatism, is it suggested to adopt accountability for 
reasonableness how an auxiliary method in the jurisdictional controls prevalent 
today? Pragmatist judge is more open to accepting contributions from other fields 
of knowledge than other judges18. In addition, he has a prospective view, antici-
pating the consequences and searching for the best possible result for society19. In 
this regard the adoption of the procedural criteria of Daniels and Sabin seems to 
be a pragmatic strategy of the judge, who, instead of limiting the discussion to the 
content of public health policies, is concerned about the requirements to be met in 
the procedure for setting priorities in order to a distribution of resources aimed a 
fair allocation, which produces desirable results for all, litigants or not.
III. The accountability for reasonableness
According to Norman Daniels and James Sabin, the legitimacy of limits and 
priorities in health care involves not only who has the moral authority to establish 
them, but how those limits and priorities are established. This is the main model 
of procedural justice for health systems applied according to the priority setting20.
For Syrret, the allocation of decision-making causes legitimacy problems. 
Since choices are made in situations of scarcity, moral disagreements and conflicts 
arise over the choice of priorities, which can result in both resistance and distrust 
of society. In response, the legitimacy of public authorities can be claimed in two 
ways: based on their expertise, which is based on the body’s ability to understand 
and fulfill its task, or on the use of a fair procedure, which is based on the existence 
17 DANIELS, Norman; SABIN, James E. Setting limits fairly: can we learn to share medical resources? New York, 
NY: Oxford University Press, 2002; e DANIELS, Norman. Accountability for reasonableness: establishing a 
fair process for priority setting is easier than agreeing on principles. BMJ, v. 321, n. 7272, p. 1300-1301, 
25, Nov.2000. https://doi.org 10.1136/bmj.321.7272.1300.
18 POSNER, Richard. A. Law, pragmatism and democracy, cit., p. 76-77.
19 POGREBINSCHI, Thamy. Pragmatismo: teoria social e política. Rio de Janeiro: Relume Demará, 2005. p. 39 e 47.
20 FRIEDMAN, Alex. Beyond accountability for reasonableness. Bioethics, v. 22, n. 2, p. 102, 2008. http://
dx.doi.org/10.1111/j.1467-8519.2007.00605.x.
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of a connection between process equity, legitimacy and public acceptance of deci-
sions, regardless of any substantive results. The accountability for reasonableness is 
based on the second form21.
The proposed fair process aims at the implementation of public accountabil-
ity, aimed at the organizations that allocate resources for the satisfaction of health 
needs, and has as fundamental elements the transparency of the decision bases, the 
use of reasons that everyone should accept as relevant to the satisfaction of health 
needs and the possibility of reviewing these decisions22. The main idea that supports 
this theory is that fair and reasonable people (fair-minded) are able to agree on the 
reasons for setting priorities when they realize that it has gone with justice and equity 
to meet everyone’s health needs..
The authors clarify the notion of accountability for reasonableness by estab-
lishing four conditions23: (i) advertising condition, according to which the reasons 
for important decisions setting limits for health needs must be accessible to the 
public; (ii) a condition of relevance, which determines that the reasons for these 
decisions must constitute a reasonable explanation of how value is sought for money 
(value for money) in order to meet the various health care needs of a given popu-
lation, considering the resources constraints; (iii) review condition, which requires 
mechanisms to review and improve public policies in the face of new evidence or 
arguments brought; and (iv) regulatory condition, which provides for public regu-
lation of the decision-making procedure to ensure that all previous conditions are 
observed. This is a democratic approach: the observance of these conditions would 
remove the decisions on health needs from the “black box” and it would become 
them accessible to society, connecting them to an “ampler deliberative and educa-
tional process democratic”24.
In this way, the accountability for reasonableness intends to collaborate to 
educate decision-makers about the indispensable aspects related to a fair decision, as 
well as to facilitate and stimulate social learning on the establishment of health pri-
orities and the limits of budgetary resources, allowing a public deliberation process.
Finally, we highlight two relevant criticisms of Daniels and Sabin’s theory25. 
The first concerns popular participation in the procedure, stating that the advertising 
21 SYRETT, Keith. Health technology appraisal and the courts: accountability for reasonableness and the 
judicial model of procedural justice. Health Economics, Policy and Law, n. 6, p. 471, 2010. https://doi.
org/10.1017/S174413311000022.
22 DANIELS, Norman; SABIN, James E. op. cit, p. 45-46.
23 Id., loc. cit.
24 DANIELS, Norman. Just health: meeting health needs fairly. Cambridge: Cambridge University Press, 
2008. p. 119.
25 RID, Annette. Justice and procedure: how does “Accountability for Reasonableness” Result in fair limit-
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condition needs to be better specified. In fact, such condition presupposes that the 
public is aware of the setting of budget limits and priorities; however, this does not 
always occur. It is important that there is active communication about allocation 
decisions, through newsletters, web pages discussion or public events, for example, 
to obtain effective publicity and even to allow people to appeal the decision. The 
second criticism states that accountability for reasonableness is not inclusive enough, 
because the mechanisms of public representation are limited. It is therefore proposed 
to expand the mechanisms of stakeholder involvement, by encouraging participation 
in debates on funding priorities, the formation of associations, etc., in order to seek 
fair consideration of everyone’s claims.
IV. How to apply the theory in court?
What is the reflection of the adoption of the theory of accountability for 
reasonableness in the role of the Judiciary in health processes? Greater jurisdictional 
control over the administrator’s decision-making procedure, regarding the inclusion 
of medicines in public lists, favors interventions more procedural than substantive.
The role of judicial bodies based on the “theory on the screen” can be dis-
cussed as an alternative to the dilemma between usurpation, resulting from the use 
of strong judicial remedies in individual demands, and abdication, resulting from 
the use of procedural control along the lines of South Africa, bringing a vision with 
other nuances to the judicial intervention.
It is expected that the result of the judicial adoption of this model will be 
a more respectful stance to complex technical decisions or to the formulation of 
public policies taken by competent bodies, at the same time that the administration is 
charged with accountability for its performance. This stance aims to encourage health 
authorities to exercise caution in the decision-making procedure and to improve it 
whenever the courts indicate flaws in it and cancel their choices.
That way, the judicial bodies would ensure compliance with the regulatory 
condition provided by Daniels and Sabin. In the words of Daniel Wang,
Thus, if courts control the quality of the decision-making 
process (whether it is open, transparent, based on acceptable 
evidence, reasons and principles that are accepted by fair-
minded people and with opportunities for interested parties to 
challenge the decision) instead of allocating scarce resources 
themselves by deciding whether an individual claimant should 
have access to a treatment, they force health authorities to ration 
explicitly and by doing it in this way create incentives for fair 
decisions. Being able to articulate the reasons for their decision 
becomes a strategy for the authorities, by which to defend their 
decisions in litigation. The courts, therefore, meet with the 
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“regulatory principle” in Daniels and Sabin’s theory: ensure that 
the other conditions of accountability for reasonableness are 
met26 (free translation).
Finally, a remark for comparative study purpose: the jurisprudence of 
England, the cradle of the public and universal health system model, is a recur-
ring example of the application of accountability for reasonableness although 
the judges do not express reference to the theory. From the 1990s, with the 
judgment of the “Child B”27case, the English courts began to demand explicit 
reasons from the authorities to support their decisions, which should be the 
result of a public and transparent procedure taking into account the context of 
the individual case. This judicial stance culminated in the creation, in 1999, of 
the so-called today as National Institute for Health and Care Excellence (NICE), 
inspired by the idea of accountability for reasonableness. Among others, NICE 
has the function of evaluating the use of new technologies, based on a clinical 
and cost-effectiveness analysis.
V. Application of the theory in Brazil
If the application of the theory of accountability for reasonableness by the 
Judiciary requires, on the one hand, that the judicial bodies be informed about how 
the allocation decisions of resources was made and about the reasons for choosing 
priorities, on the other, it requires that the health authorities, in turn, give importance 
to the decision-making procedure and regulate it - after all, if there is no attention 
from the public administration in this regard, there is no reason to defend a judicial 
control over the procedure.
In this scenario, it is questioned what would be the practical mechanisms 
of a possible application of the theory in Brazil. It is precisely at this point that the 
26 In the original: “Thus, if courts control the quality of the decision-making process (whether it is open, 
transparent, based on acceptable evidence, reasons and principles that are accepted by fair-minded 
people and with opportunities for interested parties to challenge the decision) instead of allocating scarce 
resources themselves by deciding whether an individual claimant should have access to a treatment, they 
force health authorities to ration explicitly and by doing it in this way create incentives for fair decisions. 
Being able to articulate the reasons for their decision becomes a strategy for authorities by which to defend 
their decisions in litigation. Courts, therefore, meet the ‘regulatory principle’ in Daniels and Sabin’s theory: 
they ensure the other conditions for accountability for reasonableness are fulfilled”. WANG, Daniel Wei 
Liang. Can litigation promote fairness in healthcare?: the judicial review of rationing decisions in Brazil 
and England. 2013. Tese (Doutorado) - Department of Law. The London School of Economics and Political 
Science, London, 2013. p. 18.
27 The leading case “R. versus Cambridge Health Authority, ex parte B ([1995] 2 All ER 129, [1995] 1 WLR 
898)]“ discussed an administrative decision that refused to fund leukemia treatment for a girl of 10 years 
old. The case is emblematic because Justice Laws, one of the members of the High Court, seemed to 
meet the conditions of accountability for reasonableness by requiring health authorities to explain the 
priorities that led them to deny the cost of treatment and to defend judicial deference, provided there was 
transparency as to the reasons for setting priorities.
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study of the National Commission for Technology Incorporation at SUS (Conitec), 
created by Law no. 12,401/201128.
With the proposal, it is expected that jurisdictional control will not be con-
current, but cooperative, helping to materialize social law and, therefore, tending to 
produce a more desirable result than the current form of control.
For Schapiro,
Whether in the case of telecommunications or health, distrust 
of the proper functioning of other powers and their control 
mechanisms can be a device that encourages and justifies judicial 
activism. The point is that this activism can work in a competitive 
or cooperative way. In other legal systems, such as the English, 
faced with situations like this, the Judiciary’s position is not to 
subrogate itself in the position of public manager, substantively 
choosing the form of allocation of public resource, but rather 
requiring the Executive to prove the reasonableness of your 
choice (WANG, 2013, p. 115-172). Following this path, liberal 
control does not act in a predatory way for the consistency of 
political choices, but in a cooperative way with the strengthening 
of republican control. By charging the Executive with the choice 
criteria, instead of providing individual lawsuits, the Judiciary 
encourages an improvement in impact analyzes and consistency 
of administrative choices29.
Furthermore, the adoption of the method studied here may stimulate the 
phenomenon called institutional dialogues - an expression that comes from Cana-
dian doctrine, by studying the provisions of the Canadian Charter of Rights from 
1982 that allow the decision’s modification, by Parliament, of the Supreme Court and 
facilitate the dialogue between the judicial body and the Legislative30. Thus, even-
tual judicial decisions on health care litigation, instead of closing the debate, would 
have the power to open the channels of dialogue between the Judiciary, Conitec and 
society to define the content of the right to health provided for in the Constitution.
28 BRASIL. Lei n. 12.401, de 28 de abril de 2011. Altera a Lei n. 8.080, de 19 de setembro de 1990, para 
dispor sobre a assistência terapêutica e a incorporação de tecnologia em saúde no âmbito do Sistema 
Único de Saúde - SUS. Available at: http://www.planalto.gov.br/ccivil_03/_Ato2011-2014/2011/Lei/
L12401.htm. Acesso em: 30 Aug. 2020
29 SCHAPIRO, Mario G. Discricionariedade desenvolvimentista e controles democráticos: uma tipologia dos 
desajustes. Revista Direito GV, v. 12, n. 2, p. 337, maio/ago. 2016. Available at: https://www.scielo.br/pdf/
rdgv/v12n2/1808-2432-rdgv-12-2-0311.pdf.
30 HOGG, Peter W.; BUSHELL, Alison A. The Charter dialogue between courts and legislatures (or perhaps 
the charter isn’t such a bad thing after all). Osgoode Hall Law Journal, v. 35, n. 1, p. 75, 1997. https://
digitalcommons.osgoode.yorku.ca/cgi/viewcontent.cgi?article=1612&context=ohlj&httpsredir=1&refer
er=.; e BRANDÃO, Rodrigo. Supremacia judicial versus diálogos constitucionais: a quem cabe a última 
palavra sobre o sentido da Constituição? Rio de Janeiro: Lumen Iuris, 2012. p. 273-274 e 286.
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A final comment on the mention of the theme by the Brazilian Judiciary. In 
the Extraordinary Appeal (RE) 566471, the STF recognized the general repercus-
sion of the controversy over the obligation for the government to supply high-cost 
medication. The ministers Luís Roberto Barroso and Alexandre de Moraes set out 
in their theses, as a requirement for the judicial supply of the drug, the proof that 
the failure to incorporate the drug claimed in SUS did not result from an express 
decision of the competent bodies. Barroso also demands the “establishment of an 
institutional dialogue between the Judiciary and entities with technical expertise in 
the health field”31. It is perceived, in this point, an appreciation of Conitec’s attribu-
tions and of what was decided in the administrative procedure.
Similarly, in RE 657718, in which the STF recognized the general repercus-
sion on the subject of the obligation of the State to pay for medicine not registered 
with the National Health Surveillance Agency (Anvisa), the vote of Minister Edson 
Fachin proposed the thesis that it is possible for the State to provide, as a general 
rule, the prohibition of dispensing, paying or reimbursing medicines without reg-
istration32. The vote states that, in the field of health care policies, the control of 
administrative decisions can be identified with accountability for reasonableness of 
Norman Daniels, implying a “more respectful stance to the technical or democratic 
choices made by competent bodies, without the administration or the regulatory 
entities failing to render account for their performance”, and recognizing that it is 
possible to carry out control through the reasons presented in a given public policy.
1. The National Commission for Technology Incorporation at SUS
The creation of the National Commission for Technology Incorporation at 
SUS (Conitec), a national institution that is closest to the English NICE, represents a 
legislative reaction to the increasing demand for medicines not covered by SUS and 
makes it clear that health authorities are responsible for provide reasons for those 
affected by their decisions, accessible to the whole of society, with the intention of 
reducing court interference. Bill no.  338/200733 and n.  219/200734, originated in the 
Senate and which, jointly assessed by the National Congress, were converted into 
Law no. 12,401/2011, justify the growing disputes of drug users not contemplated 
in the tables of the Ministry of Health and the need for a solution to this impasse.
31 SUPREMO TRIBUNAL FEDERAL – STF. RE 566471. Available at: http://portal.stf.jus.br/processos/detalhe.
asp?incidente=2565078.	Acesso	em:	14	out.	2020.	Nota	da	autora:	está	pendente	a	fixação	da	tese.
32 SUPREMO TRIBUNAL FEDERAL – STF. Recurso Extraordinário RE 657718. Available at: http://portal.stf.
jus.br/processos/detalhe.asp?incidente=4143144. Acesso em: 30 ago. 2020. Nota da autora: julgamento 
concluído	com	fixação	de	tese.
33 BRASIL. Senado Federal. Projeto de Lei do Senado n. 338, de 2007. Available at: https://www25.senado.
leg.br/web/atividade/materias/-/materia/81517. Acesso em: 30 Agu. 2020.
34 BRASIL. Senado Federal. Projeto de Lei do Senado n. 219, de 2007. Available at: https://www25.senado.
leg.br/web/atividade/materias/-/materia/80822. Acesso em: 30 Agu. 2020.
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The former Commission on Technology Incorporation of the Ministry of 
Health (CITEC) was the body that initiated the institutionalization of the technol-
ogy incorporation process at SUS. Conitec replaced CITEC and is responsible for 
advising the Ministry of Health on the incorporation and exclusion of new drugs, 
products and procedures, the constitution or amendment of Clinical Protocols and 
Therapeutic Guidelines (PCDT) and the updating of the National List of Essential 
Medicines (Rename) and the National List of Health Actions and Services (Renases) 
(Law n. 8.080/1990, art. 19-Q, caput)35.
Among the various objectives of the new body, the three most relevant for 
facing judicialization stand out: (i) to qualify the decision-making process in the 
evaluation of health technologies, seeking the promotion and health protection of the 
Brazilian population, the better allocation of available resources and the reduction 
of regional inequalities; (ii) to contribute to the qualification of judicial decisions 
and to the reduction of the judicialization of the right to health in the country; (iii) 
and to give visibility to the process of management and incorporation of health 
technologies.
Law no. 12,401/2011 also provided for the legal procedure on which the 
Commission’s acts are based. Social participation in the decision-making process is 
strengthened by public consultations and hearings. The procedure is provided for 
Articles 19-Q and 19-R of Law no. 8.080/1990 and Decree 7.646 / 201136.
There are also two other legal changes that have a great impact from the 
perspective of the plaintiffs: the establishment of a period of 180 days for finalizing 
the analysis of the proposal, which can be extended, at most, for another 90 days, and 
the mandatory opening administrative process for the incorporation of medicines, 
instituted by private individual, legal entity or by the Ministry of Health. The end 
of the period without the completion of the procedure, however, does not require 
the dispensing of the medicine or product.
In the reports on new technologies it issues, Conitec considers the scien-
tific evidence on its effectiveness, efficiency and safety, as well as the comparative 
economic evaluation of the benefits and costs in relation to the technologies already 
incorporated. The reports are available on the website of the Ministry of Health and 
can be a useful tool both for the interested population and for the magistrates who 
35 BRASIL. Lei n. 8.080 de 19 de setembro de 1990. Dispõe sobre as condições para a promoção, proteção 
e recuperação da saúde, a organização e o funcionamento dos serviços correspondentes e dá outras 
providências. Available at: http://www.planalto.gov.br/ccivil_03/_Ato2011-2014/2011/Lei/L12401.htm. 
Acesso em: 13 Jan. 2019.
36 BRASIL. Decreto n. 7.646, de 21 de dezembro de 2011. Dispõe sobre a Comissão Nacional de Incorporação 
de Tecnologias no Sistema Único de Saúde e sobre o processo administrativo para incorporação, exclusão 
e alteração de tecnologias em saúde pelo Sistema Único de Saúde - SUS, e dá outras providências. 
Available at: http://www.planalto.gov.br/ccivil_03/_Ato2011-2014/2011/Decreto/D7646.htm. Acesso 
em: 30 Aug. 2020.
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appreciate demands on the subject. The aim is to facilitate the transparency of the 
procedure. Transparency encourages society’ learning about health priorization 
and the limits of budgetary resources, as well as approximating the important - and 
inevitable - decision to choose the best model of technology use and allocation of 
resources for a health system that belongs to all.
The legitimacy of administrative choices is strengthened the more these 
choices are opened to participation and popular control and technically based. By 
implementing these ideals, the new procedure provided for by Law no. 12,401/2011, 
at least potentially, intends to strengthen the legitimacy of Conitec’s acts and, there-
fore, to stimulate judicial deference. To conclude, mention the lessons of Daniel 
Wang, for whom the Daniels and Sabins’s theory “has emerged in Brazil as the right 
response to the increase in health care litigation, although its effectiveness is not 
guaranteed since it depends on courts accepting the legitimacy of the new health 
technology assessment system”37 (free translation).
Finally, an elementary remark is necessary. Any analysis of Conitec’s actions 
cannot disregard the risk of “capture” by the pharmaceutical industries and private 
interests38. This aspect shows that the adoption of the judicial stance regarding the 
Commission’s choices must pay attention to the varied circumstances of the admin-
istrative procedure, including those related to the risk of capture of public officials.
2. Conitec’s performance: an empirical analysis
It is necessary to verify concretely, in the light of pragmatism, what the results 
arising from Conitec’s performance have been. Therefore, based on empirical data 
collected through bibliographic review, the context in which the demands against the 
Commission are inserted will be examined - what is required and by whom, if there 
is social participation and if it is able to influence the result of the final decision and 
whether there is an analysis of scientific and economic factors - and the consequences 
of its recommendations in relation to the incorporation, alteration or exclusion of 
medicines - what is the total number of incorporations and which technologies.
The assessment focuses on the quality of the decision-making procedure, seeking 
to analyze: (i) whether the technical basis was based on scientific evidence and on the 
comparative economic assessment of the benefits and costs in relation to the technologies 
37 In the original: “In sum, a rationing scheme along the lines of what was suggested by Daniels & Sabin 
idea of accountability for reasonableness has emerged in Brazil as the right response to the increase in 
health care litigation, although its effectiveness is not guaranteed since it depends on courts accepting the 
legitimacy of the new health technology assessment system”. WANG, Daniel Wei Liang. op. cit., p. 110.
38 KOMESAR, Neil. Imperfect alternatives: choosing institutions in law, economics, and public policy. Chicago: 
The University of Chicago Press, 1994. p. 128. On the subject, check out also: JORDÃO, Eduardo. Controle 
Judicial de uma administração pública complexa: a experiência estrangeira na adaptação da intensidade 
do controle. São Paulo: Malheiros Editores; SBDP, 2016.
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already incorporated, as well as on clear criteria (which is equivalent to compliance with 
the condition of relevance); (ii) if the reasons were accessible to society and if there was 
a public consultation, providing a dialogue with civil society, with federal entities and 
with the professional body involved with medical procedures (publicity condition); and 
(iii) whether the review of the decision was made viable (review condition).
According to a study based on public data on the Conitec page39 conducted 
by Rosângela Caetano et al.40 (experts not members of the commission) on the 
demands submitted between January 1, 2012 and June 30, 2016, the total number 
of submissions received has increased to 485, 92.2% of which refer to requests for 
incorporation of new technologies. The majority of demands for technologies are 
still related to medicines (62.1%), with 52.2% of all medicine submissions coming 
from internal demands, originating from departments and bodies of the Ministry of 
Health, from municipalities linked to the Ministry and state and municipal health 
departments. With regard to external demands, including manufacturers, medical 
societies, health and teaching and research institutions, bodies of the Judiciary, 
patient associations and patient or their family members/caregivers, 40.9% were an 
initiative of the pharmaceutical industry. Comparing the origins of the demands, the 
internal ones related to medicines were more successful, corresponding to 82.8% of 
the requests that received a favorable inclusion decision.
It is worth highlighting the conclusion of the research by Pereira et al., in 
which the health technology assessment criteria considered in 16 countries were 
identified to support recommendations on the introduction of new technologies in 
their health systems. The survey evaluated 12 reports prepared by Conitec and con-
cluded that all recommendation reports presented and considered relevant “evidence 
of efficacy/safety and security of the evaluated technology, economic evaluation and 
budgetary impact studies and the benefits of incorporating a specific technology” 
in the health system, as in the other countries studied41.
A more recent study by Yuba et al.42 analyzed 199 recommendation reports 
from Conitec issued between July 2012 and December 2016. The study confirmed 
39 COMISSÃO NACIONAL DE INCORPORAÇÃO DE TECNOLOGIAS NO SISTEMA ÚNICO DE SAÚDE – CONITEC. 
Disponível em: http://conitec.gov.br.
40 CAETANO, Rosângela; SILVA, Rondineli Mendes da; PEDRO, Érica Militão; OLIVEIRA, Ione Ayala Gualandi 
de Oliveira, BIZ, Aline Navega; SANTANA, Pamela. Incorporação de novos medicamentos pela Comissão 
Nacional de Incorporação de Tecnologias do SUS, 2012 a junho de 2016. Rev. Ciência e Saúde Coletiva, 
v. 22, n. 8, p. 2516, 2017. Available at: https://www.scielo.br/pdf/csc/v22n8/1413-8123-csc-22-08-2513.
pdf. https://doi.org/10.1590/1413-81232017228.02002017.
41 PEREIRA, Viviane Cássia; SALOMON, Flávia Cristina Ribeiro; SOUZA, Andrea Brígida de. Critérios para 
decisões sobre incorporação de tecnologias em saúde no Brasil e no mundo. Revista Eletrônica Gestão & 
Saúde,	v.	6,	v.	4,	p.	3088,	out.	2015.	Available	at:	file:///C:/Users/Samsung/AppData/Local/Temp/3313-
Texto%20do%20artigo-5844-1-10-20170920.pdf.
42 YUBA, Tania Yuka; NOVAES, Hillegonda Maria Dutilh; SOÁREZ, Patrícia Coelho de. Challenges to decision-making 
processes in the national HTA agency in Brazil: operational procedures, evidence use and Recommendations. 
Health Res. Policy and Syst., v. 16, n. 1, p. 5, May 2018. https://doi.org/10.1186/s12961-018-0319-8.
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that, of this total, most (117) were due to internal demands. Nevertheless, regarding 
these internal demands, the recommendation to incorporate the new technology 
was made in 83 reports (70.9%), of which only eight (9.6%) included a complete 
health technology assessment. The authors considered as complete the evaluation 
of health technology that met the following criteria: description of the technology 
and its current uses; safety and effectiveness assessment; cost-effectiveness analysis; 
financial impact information and systematic review43. Among the external demands, 
the incorporation of the new technology was made in 13 reports (17.3%), but ten of 
them (76.9%) included that complete assessment. Based on this finding, the study 
points out differences between internal and external demands in relation to the 
evidence used in the reports, as well as some non-conformity between the charac-
teristics of the evidence used in the reports and those considered as mandatory in 
Conitec’s internal regulations.
Regarding the recommendation phase of Conitec, the study by Rosângela 
Caetano et al., which covered 201 reports dated from January 2012 to June 2016, 
identified that about 70% (139) were subject to public consultation, while 62 included 
simplified processes44. Indeed, the number of public consultations and contributions 
has increased since the creation of Conitec. By October 2014, 97 public consultations 
had been carried out and more than 5,000 contributions had been received, more 
than half not from specialists, but from people who use the SUS, such as patients 
and family members, with most of the contributions concentrated in the states of 
the South and Southeast. As of July 2015, the total number of published public con-
sultations was 123, with over 16,000 contributions on the technologies analyzed45.
In fact, in the period from 2012 to 2016, 18.8% of the preliminary recom-
mendations for not incorporating the medicines initially made by the Commission 
were modified after the public consultation. The changes were motivated by the pre-
sentation of new evidence of safety and effectiveness, new economic and budgetary 
impact assessments and proposals to reduce prices46.
From January 2012 to July 2015, 132 new technologies were incorporated into 
SUS based on the recommendations of Conitec, increasing to 314 by September 202047.
43 Id. Ibid., p.3.
44 CAETANO, Rosângela; SILVA, Rondineli Mendes da; PEDRO, Érica Militão; OLIVEIRA, Ione Ayala Gualandi de 
Oliveira, BIZ, Aline Navega; SANTANA, Pamela. op. cit., p. 2516.
45 RABELO, Roberta Buarque; PETRAMALE, Clarice Alegre; SILVEIRA, Lívia Costa da; SANTOS, Vania Cristina 
Canuto; GONÇALVES, Helcio Caixeta. A comissão nacional de incorporação de tecnologias no SUS: um 
balanço dos primeiros anos de atuação. Revista Eletrônica Gestão & Saúde, v. 6, n. 4, p. 3236-3237, out. 
2015. Available at: https://periodicos.unb.br/index.php/rgs/article/view/3326/3012.
46 CAETANO, Rosângela; SILVA, Rondineli Mendes da; PEDRO, Érica Militão; OLIVEIRA, Ione Ayala Gualandi de 
Oliveira, BIZ, Aline Navega; SANTANA, Pamela. op. cit., p. 2521.
47 Information extracted from the commission’s website. COMISSÃO NACIONAL DE INCORPORAÇÃO DE TECNOLOGIAS 
NO SISTEMA ÚNICO DE SAÚDE – CONITEC. Disponível em: http://conitec.gov.br. Acesso em: 14 out 2020.
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Regarding the deadline for completing the procedure, specifically regard-
ing the submissions related to medicines made from January 2012 to June 2016, 
of the 301 demands, 287 (95.3%) were concluded, leaving only 14 without a final 
decision. During this period, the average time for issuing recommendations from 
the Commission was 134 days48.
Finally, studies indicate that institutional dialogue between health author-
ities and public bodies dealing with legal disputes is taking place, albeit incipient. 
In the period from January 2012 to August 2014, Conitec answered 701 questions 
regarding the incorporation of technologies at SUS, formulated mainly by the Judi-
ciary and the Public Prosecutor’s Office, in addition to making an electronic mail 
channel available for direct dialogue and more agile with magistrates49.
Naturally, it cannot be generally stated that Conitec’s administrative pro-
cedure fulfills the conditions of the accountability for reasonableness theory, which 
would be an unacceptable idealization of the body. It is only suggested, based on 
the data above, that the Commission demonstrates that it is acting in an attempt 
to materialize the provisions of Law no.  12,401/2011, through a procedure based 
on technical-scientific and transparent foundations. The punctual examination of 
each demand submitted to it will allow a more secure conclusion. As the study by 
Yuba et al. concludes, Conitec is a very recent body and has contributed with many 
advances in the incorporation of technologies, although it still goes through an 
implementation process50, reinforcing the need for judicial control of the procedure.
Two final remarks are timely. The medicines intended in the lawsuits of 
greater economic weight for the health system are, for the most part, not subject 
to prior submission to the appreciation of Conitec with a view to incorporation. 
Of the 25 medicines whose lawsuits most consumed Union resources from 2012 to 
2014, 20 of them were never submitted to the Commission’s evaluation at any time. 
The five that had their claims submitted did not result in incorporation, for differ-
ent reasons51: From this, it is concluded, on the one hand, that the increase in the 
judicialization of health has different causes, which cannot be seen only as a result 
of the technology assessment process established for the country, and, on the other, 
that a greater use of Commission services by society, industries and public bodies, 
transferring the discussion about the incorporation of technologies to it, could be 
a way to help in the reduction of lawsuits.
48 CAETANO, Rosângela; SILVA, Rondineli Mendes da; PEDRO, Érica Militão; OLIVEIRA, Ione Ayala Gualandi de 
Oliveira, BIZ, Aline Navega; SANTANA, Pamela. op. cit., p. 2516.
49 MINISTÉRIO DA SAÚDE. Balanço Conitec: 2012-2014. Brasília-DF: Ministério da Saúde, 2014. p. 37. 
Disponível em: www.conitec.gov.br. Acesso em: 09 out. 2018.
50 YUBA, Tania Yuka; NOVAES, Hillegonda Maria Dutilh; SOÁREZ, Patrícia Coelho de. op. cit., p. 8.
51  For the list and reasons, see: COMISSÃO NACIONAL DE INCORPORAÇÃO DE TECNOLOGIAS NO SISTEMA 
ÚNICO DE SAÚDE – CONITEC. Nota de esclarecimento à Interfarma. Available at: http://conitec.gov.br/
images/pdf/Esclarecimentos_Interfarma.pdf. Acesso em: 14 Oct. 2020. p. 7-8.
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The second observation concerns the study by Daniel Wang on the effects 
of the creation of the English NICE in relation to judicialization. The author made 
some observations52. (i) Before the existence of NICE, patients took actions based 
on the general duty of management to provide comprehensive health care. After 
NICE, disputes requests were restricted to new and more expensive medicines or 
tried to prove that the treatment restriction provided for by NICE would not apply 
to the case, since there was an exception to the signed guidance. (ii) In cases where 
a NICE guideline that did not recommend the required treatment was challenged, 
the requests were based on procedural issues, such as the lack of transparency or 
expertise of the institution’s specialists. As these issues are more sophisticated and 
complex, the demands were filed by pharmaceutical companies or patient associa-
tions. (iii) There was a change in the burden of proof. Before NICE, the authorities 
tried to discharge the burden of proving that there were reasons for not fulfilling the 
duty of health care in some cases. With the creation of NICE, in situations where 
there was already an orientation from it, the courts considered that the reasons 
provided by the administration, in principle, were legitimate and transferred the 
burden of proof, in most cases, to the plaintiff.
VI. Some parameters of judicial application of accountability for 
reasonableness
In the light of pragmatism and its attitude committed to reality, and based 
on the theory of accountability for reasonableness, we address some minimum 
parameters for the judicial application of the procedural control dealt with.
Regarding the demands for medicines not included in the SUS list or for 
use outside the scope of the clinical protocols and in which Conitec decided against 
incorporation, the judges and courts must, as a rule, defer to the technical decision 
and reject the request.
Using the theory of accountability for reasonableness, it is suggested to 
the Judiciary, exceptionally, to examine, if any, challenges about the quality of the 
decision-making procedure, transferring the burden of proof to the plaintiff who, 
normally, does not it will be an individual, given the complexity of the issue. Cite 
the example in which it is intended to demonstrate that the restriction of treatment 
provided by Conitec would not apply to the case. In this hypothesis, it is up to the 
judge to verify: (i) if the technical reasoning was based on scientific evidence and 
on the cost-effectiveness assessment, if there was production of evidence compatible 
with the complexity of the case and if the reasons for the decision were clearly indi-
cated, they are accepted by reasonable people and lead to the conclusion reached by 
the health authority; (ii) whether the reasons were accessible to society and whether 
52 WANG, Daniel Wei Liang. op. cit., p. 216-220.
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public consultation was permitted; and (iii) whether the appeal or the review of the 
decision was provided. The judicial presentation of the Conitec report can be useful 
to allow this verification.
Once the conditions are met, the application is rejected. If any of the condi-
tions are not fulfilled, the jurisdictional control is authorized to request the health 
authorities’ opinion on aspects that were not considered or to annul the adminis-
trative decision.
In relation to the demands in which there was no appreciation of the 
incorporation, as in cases of new and more expensive medicines, it is suggested, 
as a requirement for urgent or definitive judicial protection, the prior summons 
of Conitec for an administrative procedure to be carried out, although simplified, 
observing conditions (i), (ii) and (iii) above, within a reasonable time, allowing the 
scientific community to appreciate the issue. In order to grant the request, a positive 
conclusion from Conitec is required based on scientific evidence and the cost-ef-
fectiveness assessment, since the appreciation within the individual demand must 
have the possibility of being universalized. Only exceptional cases would allow the 
judge to decide differently from that conclusion.
Thus, the argumentative burden of the author increases to justify that his 
situation receives a different treatment in relation to other SUS users. It should 
be noted that, contrary to what occurs in a significant part of the current judicial 
demands, the argumentative burden is not limited to the presentation of a pre-
scription or the report of the applicant’s doctor stating the need for the medicine 
and the lack of available and adequate therapeutic substitute for your treatment. It 
is necessary to present more robust technical foundations that support the request 
and the assessment of the administrative procedure.
Conclusion
Let’s go back to the examples in the Introduction. In a scenario of scarcity of 
resources, who should decide between increasing health care to prevent the prema-
ture death of patients with diseases such as diabetes and providing treatment for rare 
diseases with expensive medicines that can also compromise the lives of patients? 
Will it still be possible to universalize health provision, granting it to all the needy, 
litigants or not? These are issues involving distributive justice considerations that 
do not have their own locus in the Judiciary.
Under this perspective, the proposal of the accountability procedural crite-
ria for reasonableness is a pragmatic strategy that intends to equip the judges with 
the means to face the problems resulting from excessive judicialization, with the 
adoption of a contextual, empiricist and attentive to the practical results stance.
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This is not intended, it is good to clarify, an abstention by the Judiciary in the 
implementation of the right to health - the studied procedural control does not reduce 
it to this role. In comparison with the prevailing model, the proposal has the virtue of 
requiring that public administration be accountable for its performance and demonstrates 
the reasons for allocation decisions in pharmaceutical care. In this way, jurisdictional 
control would prove to be cooperative and tending to de-judicialize the debate.
As is supposed, the proposal is not a panacea for reducing the judicialization 
of health; it is just another alternative that deserves to be discussed. There is no easy 
solution to a difficult problem, and different results - perhaps better - will not be 
achieved if alternative hypotheses are not tested. It was right who said that “insanity 
is to keep doing the same thing and expect different results”53.
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